Future prospective, randomized trials with larger cohorts should standardize nutritional protocols, document enteral nutrition details, track anti-VEGF usage, and include longitudinal follow-up to evaluate sustained effects of lipid emulsions on ROP severity and neurodevelopment. The gene discussed is VEGFA; the disease is retinopathy of prematurity.